Evista (raloxifene)

  • Medical Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

GENERIC NAME: raloxifene

BRAND NAME: Evista

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

USES:

  • Evista is prescribed for the prevention and treatment of osteoporosis in post-menopausal women.
  • Supplemental vitamin D should be added to the diet if daily intake is not adequate.

WARNING: (BLACK BOX WARNING):

  • Evista may increase the risk of deep vein thrombosis (DVT) and pulmonary embolism. Therefore, women with active or past history of venous thromboembolism should not take Evista.
  • Evista increased the risk of death from stroke in a clinical trial of postmenopausal women with a history of coronary heart disease or women with a high risk of serious heart related conditions. Consider risk-benefit balance in women at risk for stroke.

SIDE EFFECTS:

The most common side effects of Evista are:

Other side effects include:

Possible serious side effects include:

Evista may increase blood triglyceride levels in some individuals Evista increases the risk of blood clots, including stroke, deep vein thrombosis (DVT), and pulmonary embolism (blood clots in the lung). The greatest increase in risk occurs during the first 4 months of use. Patients taking Evista should avoid prolonged periods of restricted movement during travel when blood clots are more prone to occur. Patients should move around periodically during long trips.

Medically Reviewed by a Doctor on 9/30/2016

Quick GuideWhat Is Osteoporosis? Treatment, Symptoms, Medication

What Is Osteoporosis? Treatment, Symptoms, Medication
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

See more info: raloxifene on RxList
RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Women's Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors